WO2002074288A3 - Composés chimiques - Google Patents
Composés chimiques Download PDFInfo
- Publication number
- WO2002074288A3 WO2002074288A3 PCT/GB2002/001220 GB0201220W WO02074288A3 WO 2002074288 A3 WO2002074288 A3 WO 2002074288A3 GB 0201220 W GB0201220 W GB 0201220W WO 02074288 A3 WO02074288 A3 WO 02074288A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- sexual dysfunction
- tetrahydrobenz
- ssri
- carboxamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002246228A AU2002246228A1 (en) | 2001-03-15 | 2002-03-15 | Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0106446.8 | 2001-03-15 | ||
GBGB0106446.8A GB0106446D0 (en) | 2001-03-15 | 2001-03-15 | Chemical compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002074288A2 WO2002074288A2 (fr) | 2002-09-26 |
WO2002074288A3 true WO2002074288A3 (fr) | 2003-02-27 |
Family
ID=9910774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2002/001220 WO2002074288A2 (fr) | 2001-03-15 | 2002-03-15 | Composés chimiques |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002246228A1 (fr) |
GB (1) | GB0106446D0 (fr) |
WO (1) | WO2002074288A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
JP2007516949A (ja) * | 2003-07-16 | 2007-06-28 | ファイザー・インク | 性機能不全の治療 |
US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
ES2646326T3 (es) | 2005-08-03 | 2017-12-13 | Sprout Pharmaceuticals, Inc. | Uso de flibanserina en el tratamiento de la obesidad |
DE602007004615D1 (de) | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
CL2008002693A1 (es) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
CA2686480A1 (fr) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | Nouveaux sels |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0633023A2 (fr) * | 1993-06-10 | 1995-01-11 | Eli Lilly And Company | Prévention de l'émésis et traitement de la dysfunctionnement sexuelle par des tétrahydro(CD)indole-6-carboxamides |
-
2001
- 2001-03-15 GB GBGB0106446.8A patent/GB0106446D0/en not_active Ceased
-
2002
- 2002-03-15 AU AU2002246228A patent/AU2002246228A1/en not_active Abandoned
- 2002-03-15 WO PCT/GB2002/001220 patent/WO2002074288A2/fr not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0633023A2 (fr) * | 1993-06-10 | 1995-01-11 | Eli Lilly And Company | Prévention de l'émésis et traitement de la dysfunctionnement sexuelle par des tétrahydro(CD)indole-6-carboxamides |
US5703112A (en) * | 1993-06-10 | 1997-12-30 | Eli Lilly And Company | Method of preventing emesis using tetrahydrobenz CD!indole-6-carbonxamides |
Non-Patent Citations (1)
Title |
---|
BEERS M H AND BERKOW R: "The Merck Manual", 1999, MERCK RESEARCH LABORATORIES, WHITEHOUSE STATION, N.J., XP002215956 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002074288A2 (fr) | 2002-09-26 |
AU2002246228A1 (en) | 2002-10-03 |
GB0106446D0 (en) | 2001-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0004170A2 (hu) | Eljárás és anyagok nyálkaszövetek gyulladásának kezelésére és megelőzésére | |
JP2005532372A5 (fr) | ||
EP1944322A3 (fr) | Traitement des troubles associés au TND alpha | |
PE20040751A1 (es) | COMPOSICION FARMACEUTICA QUE COMPRENDE DOSIS BAJAS DE UN INHIBIDOR DEL TNFalfa HUMANO | |
MXPA04005790A (es) | Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona. | |
EP1889614A3 (fr) | Procédés d'utilisation d'inhibiteurs de récapture de la sérotonine sélective à départ rapide pour le traitement de dysfonctionnements sexuels | |
WO2002069945A3 (fr) | Nouvelles preparations de medicaments a base d'anticholinergiques et d'inhibiteurs pde-iv | |
PT1387681E (pt) | Compostos antivirais | |
WO2004039325A3 (fr) | Compositions contenant un inhibiteur de jnk destinees a traiter, prevenir, gerer et/ou modifier la douleur, et leurs methodes d'utilisation | |
WO2003005960A3 (fr) | Nouveaux cannabinoides bicycliques et tricycliques | |
WO2006002096A3 (fr) | Faibles doses de l-citrulline pour traiter des maladies | |
WO2002094196A3 (fr) | Methode de traitement de cancers associes a des niveaux de her-2 eleves | |
GB0130677D0 (en) | Medicaments and novel compounds | |
JP2004537500A5 (fr) | ||
WO2002074288A3 (fr) | Composés chimiques | |
MY143278A (en) | Treatment of neurotic disorders. | |
MXPA04011835A (es) | Tratamiento de combinacion para la depresion y ansiedad. | |
TW200420290A (en) | Methods for the treatment, prevention and management of macular degeneration | |
WO2003015690A3 (fr) | Methode de traitement de l'insomnie primaire | |
NZ528164A (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
GEP201606538B (en) | Preoperative treatment of post operative pain | |
DE60236927D1 (de) | Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba | |
WO2003051301A3 (fr) | Utilisation d'arn bicatenaire lors d'une intervention therapeutique strategique d'une therapie antiretrovirale hautement active | |
GB0111497D0 (en) | Therapeutic methods | |
EP1260221A3 (fr) | Therapie de combinaison de la depression et de l'anxieté |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |